TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
27 hedge funds and large institutions have $5.6M invested in Talis Biomedical Corporation Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.6K | |
| 2 | +$11.3K | |
| 3 | +$6.29K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.93K |
| 5 |
Jane Street
New York
|
+$1.73K |
Top Sellers
| 1 | -$37K | |
| 2 | -$21.9K | |
| 3 | -$11.6K | |
| 4 |
Millennium Management
New York
|
-$10.7K |
| 5 |
Man Group
London,
United Kingdom
|
-$9K |